These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1649506)

  • 21. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis.
    Lee WM; Wang W
    J Virol; 2003 Jun; 77(11):6235-44. PubMed ID: 12743280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.
    Wiegers K; Uhlig H; Dernick R
    Virology; 1989 Jun; 170(2):583-6. PubMed ID: 2471354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.
    Zhang A; Geisler SC; Smith AD; Resnick DA; Li ML; Wang CY; Looney DJ; Wong-Staal F; Arnold E; Arnold GF
    Biol Chem; 1999 Mar; 380(3):365-74. PubMed ID: 10223339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhinovirus-mediated endosomal release of transfection complexes.
    Zauner W; Blaas D; Kuechler E; Wagner E
    J Virol; 1995 Feb; 69(2):1085-92. PubMed ID: 7815487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region.
    Skern T; Sommergruber W; Blaas D; Gruendler P; Fraundorfer F; Pieler C; Fogy I; Kuechler E
    Nucleic Acids Res; 1985 Mar; 13(6):2111-26. PubMed ID: 2987843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
    Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
    J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
    Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N
    J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translation and replication properties of the human rhinovirus genome in vivo and in vitro.
    Todd S; Towner JS; Semler BL
    Virology; 1997 Mar; 229(1):90-7. PubMed ID: 9123881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model for the differential stabilities of rhinovirus and poliovirus to mild acidic pH, based on electrostatics calculations.
    Warwicker J
    J Mol Biol; 1992 Jan; 223(1):247-57. PubMed ID: 1309885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus.
    Katpally U; Smith TJ
    J Virol; 2007 Jun; 81(12):6307-15. PubMed ID: 17428846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The atomic structure of Mengo virus at 3.0 A resolution.
    Luo M; Vriend G; Kamer G; Minor I; Arnold E; Rossmann MG; Boege U; Scraba DG; Duke GM; Palmenberg AC
    Science; 1987 Jan; 235(4785):182-91. PubMed ID: 3026048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capsid structure and dynamics of a human rhinovirus probed by hydrogen exchange mass spectrometry.
    Wang L; Smith DL
    Protein Sci; 2005 Jun; 14(6):1661-72. PubMed ID: 15883190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleotide sequences of the VP1 capsid proteins of wild poliovirus types 1 and 3 from epidemic areas of Brazil.
    Da-Silva EE; Schatzmayr HG; Kew OM
    Braz J Med Biol Res; 1990; 23(1):1-5. PubMed ID: 2167137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.
    Mani B; Baltzer C; Valle N; Almendral JM; Kempf C; Ros C
    J Virol; 2006 Jan; 80(2):1015-24. PubMed ID: 16379002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
    Hastings GZ; Speller SA; Francis MJ
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for at least two dominant neutralization antigens on human rhinovirus 14.
    Sherry B; Rueckert R
    J Virol; 1985 Jan; 53(1):137-43. PubMed ID: 2981332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
    Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canine parvovirus capsid assembly and differences in mammalian and insect cells.
    Yuan W; Parrish CR
    Virology; 2001 Jan; 279(2):546-57. PubMed ID: 11162810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.